Humana stock falls after losing Medicare bonus payment lawsuit

Investing.com -- Humana Inc (NYSE: HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted other health insurers, with CVS Health (NYSE: CVS) and UnitedHealth Group (NYSE: UNH) shares declining 2%.

According to Bloomberg, a Texas district court ruled in favor of the government’s motion to dismiss Humana’s case, which sought to reverse cuts to its Medicare bonus payments. The ruling affirms Medicare’s downgrade of Humana’s quality ratings, a decision that will likely reduce the company’s profits in 2026.

The lawsuit was a key attempt by Humana to restore what could amount to billions in revenue. The company had challenged the government’s decision to reduce its quality ratings, which directly impact the bonus payments health insurers receive for Medicare Advantage plans.

Medicare Advantage plans, which are privately managed alternatives to traditional Medicare, represent a significant portion of revenue for major health insurers. The government uses a star-rating system to evaluate plan quality, with higher ratings qualifying insurers for bonus payments.

You May Also Be Interested In

• S&P Global shares rise on report of possible CapIQ spinoff
• NSJ Gold Corp. (NSJ) (9PZ) Increases Flow-Through Financing for Exploration on Its Antimony 2.0 Property
• Los Andes Copper Announces Election to Issue Common Shares in Satisfaction of US$9 Million Convertible Debenture Interest Payment Obligations